Skip to main content

Day: May 10, 2024

Healthier Choices Management Corp. Reports First Quarter 2024 Financial Results

–First Quarter Record Sales of $15.9 Million, Up 17%, over Q1 2023 -First Quarter Record Gross Profit of $6.1 Million Up 23%, over Q1 2023 HOLLYWOOD, FL, May 10, 2024 (GLOBE NEWSWIRE) — Healthier Choices Management Corp. (OTC Pink: HCMC) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Results Highlights:Net sales from operations for the three-month period ended March 31, 2024, amounted to a record $15.9 million, compared to $13.6 million, an approximately $2.3 million and 17% increase versus the same period in 2023. Gross Profit from operations increased by approximately $1.1 million for the three-month period ended March 31, 2024, amounting to a record $6.1 million, compared to $4.9 million for the same period in 2023, a 23% year-over-year increase. Net Loss for the three-month...

Continue reading

SoundThinking to Present at the 19th Annual Needham Technology, Media, & Consumer Conference on May 15, 2024

FREMONT, Calif., May 10, 2024 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI) (formerly ShotSpotter, Inc.), a leading public safety technology company, will be presenting at the 19th Annual Needham Technology, Media, & Consumer Conference being held at the Westin Grand Central Hotel in New York City on Wednesday, May 15, 2024. SoundThinking’s Chief Financial Officer, Alan Stewart, will be presenting at 8:45 a.m. Eastern Time. In addition to the public presentation, Stewart will be holding one-on-one meetings with institutional investors throughout the day. The company’s presentation will be webcast live and available for replay here. For additional information or to schedule a one-on-one meeting with management, please contact your Needham representative or SoundThinking’s investor relations team at SSTI@gateway-grp.com. About...

Continue reading

Safe & Green Holdings Contract with Government Contractor Increased by Approximately $1 Million to Construct 11 Additional Military Office Containers

Modular office containersModular office containersModular office containers MIAMI, May 10, 2024 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced that a current military contract has been increased again, as of May 9, 2024, by approximately $1.0 million, with more than $900,000 of that change order being allocated to 11 new office containers. Paul Galvin, Chairperson and CEO of Safe and Green Holdings, stated, “I am excited to announce that a principal government contractor has augmented our original agreement, which involved refurbishing 19 modular units, to now include the construction of 11 new build modular office containers. These stackable, modular, non-combustible...

Continue reading

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

BERKELEY HEIGHTS, N.J., May 10, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that management will be participating in fireside chats and investor meetings at both the JMP Securities Life Sciences Conference being held in New York on May 13 – 14, 2024 and the 2024 RBC Capital Markets Global Healthcare Conference being held in New York on May 14 – 15, 2024. Details for each fireside chat are as follows:JMP Securities Life Sciences ConferenceDate:   Tuesday, May 14, 2024Time:   9:30am EDTWebcast:   Click here     RBC Capital Markets Global Healthcare ConferenceDate:   Wednesday, May 15, 2024Time:   1:35pm EDTWebcast:   Click here     A replay...

Continue reading

Flywire to Attend Upcoming Investor Conferences

BOSTON, May 10, 2024 (GLOBE NEWSWIRE) — Flywire Corporation (Nasdaq: FLYW)(“Flywire” or the “Company”) a global payments enablement and software company, today announced that the Company’s management team will be attending the following upcoming investor conferences:On Tuesday, May 21, 2024, the Company will attend the J.P. Morgan Technology, Media & Communications Conference in Boston, MA. They will participate in a fireside chat discussion which will begin at 4:25pm ET. On Wednesday, June 5, 2024, the Company will attend the William Blair Growth Conference in Chicago, IL. They will participate in a fireside chat discussion which will begin at 2:40pm CT. On Monday, June 10, 2024, the Company will attend the Morgan Stanley US Financials, Payments & CRE Conference in New York, NY. They will participate...

Continue reading

iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

– Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 GALAXIES Lung-201– Clinically meaningful tumor reduction observed at every belrestotug + dostarlimab dose vs monotherapy– GSK to provide update on GALAXIES program at upcoming investor event in June– RA Capital and Boxer Capital led $120 million registered direct offering at $17.50, representing a premium of approximately 44% to last close– Pro forma cash and investment balance of $715 million as of March 31, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones WATERTOWN, Mass. and GOSSELIES, Belgium, May 10, 2024 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company...

Continue reading

Telos Corporation Announces First Quarter Results Above Guidance: Reports $29.6 Million of Revenue, 37.0% GAAP Gross Margin, and 42.2% Cash Gross Margin

Reports First Quarter Results Above High End of Guidance Range on Key Financial Metrics Delivered $29.6 Million of Revenue, Reflecting Outperformance by Security Solutions Generated 37.0% GAAP Gross Margin; Expanded Cash Gross Margin by 249 Basis Points to 42.2% Cash Flow From Operations Was a Modest $0.4 Million Outflow; Free Cash Flow Improved Year-Over-Year Revenues Expected to Return to Sequential Growth in the Third or Fourth Quarter of 2024, Subject to Favorable Resolution of Protests on Typical TimetableASHBURN, Va., May 10, 2024 (GLOBE NEWSWIRE) —  Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced financial results for the first quarter of 2024. “I am pleased to report Telos exceeded the high end...

Continue reading

Whitestone REIT Urges Shareholders to Support Its Highly Qualified Trustee Nominees at the Annual Meeting on May 14 – Vote Today Using the White Proxy Card

Whitestone’s Turnaround Strategy Has Been Successful Under New Board / Leadership Team Our Reset Strategy Has Momentum and the Market Is Recognizing Our Accomplishments Do Not Let Erez Interrupt Our Momentum, Derail Our Strategy and Destroy Value Glass Lewis and Egan Jones, Two Leading Proxy Advisory Firms, Both Recommended that Shareholders Vote “FOR ALL” of Whitestone’s Board Nominees on the WHITE Proxy Card HOUSTON, May 10, 2024 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE:WSR) (“Whitestone” or the “Company”) today announced that it has issued a letter to shareholders related to the upcoming 2024 Annual Meeting of Shareholders scheduled to be held on May 14, 2024. The letter urges shareholders to vote the WHITE proxy card “FOR ALL” of Whitestone’s highly qualified trustees standing for election. The...

Continue reading

Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky

Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif., May 10, 2024 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the Ekso Indego Personal will be featured on ‘Health Uncensored’ hosted by Dr. Drew Pinsky. The episode is scheduled to air on the Fox Business News channel on Sunday, May 12 at 5:30 p.m. ET / 2:30 p.m. PT. Scott Davis, Chief Executive Officer of Ekso Bionics, Michael Glover, Director of Clinical Operations of Ekso Bionics, and Jim Gritton, an Ekso Indego Personal device user, will join Dr. Drew to share the user reported benefits and advanced technology of the Ekso Indego Personal, a powered exoskeleton that is designed to provide patients...

Continue reading

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

MORRISVILLE, N.C., May 10, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data related to the investigational use of L606 (liposomal treprostinil) inhalation suspension in people with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) at the American Thoracic Society (ATS) 2024 International Conference, taking place May 17-22, 2024, in San Diego, California. Rajeev Saggar, MD, chief medical officer at Liquidia, said: “We are pleased to be presenting initial data on the safety and tolerability of L606 from our on-going, open-label study in the United States. We believe that the initial data supports our continued confidence that twice-daily dosing is tolerable, titratable and supports further investigation as we...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.